Clinical Significance of T2-Weighted Sequence Intensity on Magnetic Resonance Imaging in Clinically Non-Functioning Pituitary Adenomas
Experimental and Clinical Endocrinology & Diabetes · 01.12.2023 · 131 (12) · 631-638
DOI: 10.1055/a-2197-3566 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Experimental and Clinical Endocrinology & Diabetes, erschienen am 01.12.2023. Verfasst von Pedro Iglesias und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda (Majadahonda), Madrid, Spain. Instituto de Investigación Sanitaria P…. Hauptthemen laut MEDLINE: Adenoma, Pituitary Neoplasms. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Background
Little is known about the relationship between signal intensity patterns on T2-weighted magnetic resonance imaging (MRI) in non-functioning pituitary adenomas (NFPAs).
Objective
In this study, the clinical, hormonal, histological features, and therapeutic responses were evaluated according to the T2 signal intensity in NFPAs.
Methods
This retrospective and multicenter study included a group of 166 NFPA patients (93 men, 56%, mean age 58.5 ±14.8 yr).
Results
Approximately half of the tumors (n=84, 50.6%) were hyperintense, while 34.3% (n=57) and 15.1% (n=25) were iso- and hypointense, respectively. The median maximum tumor diameter of the isointense group [16 (13–25) mm] was significantly lower than that of the hyperintense [23 (16.6–29.7) mm] group (p=0.003). Similarly, the tumor volume of the isointense group [1,523 (618–5,226) mm3] was significantly lower than that of the hyperintense [4,012 (2,506–8,320) mm3] group (p=0.002). Chiasmatic compression occurred less frequently in tumors with isointense signal characteristics (38.6%) compared to tumors with hypointense (68%) and hyperintense (65.5%) signal characteristics (p=0.003). Invasive adenomas (p=0.001) and the degree of cavernous sinus invasion (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Endocrinology, Hospital Universitario Puerta de Hierro Majadahonda (Majadahonda), Madrid, Spain. Instituto de Investigación Sanitaria Puerta de Hierro Segovia de Arana (IDIPHISA).
- Department of Endocrinology, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
- Department of Endocrinology, Hospital Universitario Ramón y Cajal, Madrid, Spain.
- Department of Endocrinology, Hospital Universitario Severo Ochoa, Leganés, Madrid, Spain.
- Department of Endocrinology, Hospital Universitari de Bellvitge (L'Hospitalet de Llobregat), Barcelona, Spain.
- Department of Endocrinology, Complexo Hospitalario Universitario de A Coruña and Universidad de A Coruña, Spain.
Zitieren
APA
Iglesias, P., Biagetti, B., Araujo-Castro, M., Alcázar, V., Guerrero-Pérez, F., Rivero, N., Casteràs, A., Gómez, C. G., Izquierdo, B. G., Torres, V. V., Pascual-Corrales, E., Pavón, I., Villabona, C., Cordido, F., & Díez, J. J. (2023). Clinical Significance of T2-Weighted Sequence Intensity on Magnetic Resonance Imaging in Clinically Non-Functioning Pituitary Adenomas. Experimental and Clinical Endocrinology & Diabetes, 131(12), 631-638. https://doi.org/10.1055/a-2197-3566
Vancouver
Iglesias P, Biagetti B, Araujo-Castro M, Alcázar V, Guerrero-Pérez F, Rivero N, et al. Clinical Significance of T2-Weighted Sequence Intensity on Magnetic Resonance Imaging in Clinically Non-Functioning Pituitary Adenomas. Experimental and Clinical Endocrinology & Diabetes. 2023;131(12):631-638. doi:10.1055/a-2197-3566
BibTeX
@article{Iglesias2023,
author = {Iglesias, Pedro and Biagetti, Betina and Araujo-Castro, Marta and Alcázar, Victoria and Guerrero-Pérez, Fernando and Rivero, Noelia and Casteràs, Anna and Gómez, Carlos García and Izquierdo, Belén García and Torres, Víctor Viedma and Pascual-Corrales, Eider and Pavón, Isabel and Villabona, Carles and Cordido, Fernando and Díez, Juan J},
title = {Clinical Significance of T2-Weighted Sequence Intensity on Magnetic Resonance Imaging in Clinically Non-Functioning Pituitary Adenomas},
journal = {Experimental and Clinical Endocrinology & Diabetes},
year = {2023},
volume = {131},
number = {12},
pages = {631--638},
doi = {10.1055/a-2197-3566}
}
EUVIMED